Clinical Trials - NBTX

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT03589339NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 TherapyRECRUITINGPHASE12019-01-162028-05-302027-04-30
NCT02805894NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate AdenocarcinomaTERMINATEDPHASE1, PHASE22017-11-152020-03-192020-03-19
NCT02721056NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver CancersTERMINATEDPHASE1, PHASE22016-01-282020-05-062020-05-06
NCT02379845NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk WallCOMPLETEDPHASE2, PHASE32015-03-032020-09-202018-05-22
NCT01946867NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or OropharynxUNKNOWNNA2014-01-032023-022023-02
NCT01433068NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the ExtremityCOMPLETEDPHASE12011-102015-022014-05